Jefferies Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $16.2M | Buy |
+71,900
| New | +$17.4M | 0.14% | 117 |
|
|
2021
Q3 | – | Sell |
-1,600
| Closed | -$390K | – | 1694 |
|
|
2021
Q2 | $390K | Hold |
1,600
| – | – | ﹤0.01% | 1241 |
|
|
2021
Q1 | $398K | Sell |
1,600
-9,200
| -85% | -$2.2M | ﹤0.01% | 1180 |
|
|
2020
Q4 | $2.48M | Hold |
10,800
| – | – | 0.02% | 641 |
|
|
2020
Q3 | $2.75M | Buy |
10,800
+5,800
| +116% | +$1.44M | 0.03% | 457 |
|
|
2020
Q2 | $1.18K | Sell |
5,000
-17,800
| -78% | -$4.06M | 0.01% | 713 |
|
|
2020
Q1 | $4.75M | Sell |
22,800
-2,500
| -10% | -$546K | 0.05% | 341 |
|
|
2019
Q4 | $6.1M | Sell |
25,300
-75,600
| -75% | -$16.7M | 0.05% | 430 |
|
|
2019
Q3 | $19.5M | Sell |
100,900
-111,500
| -52% | -$21.4M | 0.15% | 86 |
|
|
2019
Q2 | $39.1M | Buy |
212,400
+210,500
| +11,079% | +$37.7M | 0.29% | 44 |
|
|
2019
Q1 | $361K | Sell |
1,900
-4,400
| -70% | -$840K | ﹤0.01% | 1729 |
|
|
2018
Q4 | $1.23M | Sell |
6,300
-109,100
| -95% | -$21.3M | 0.01% | 1060 |
|
|
2018
Q3 | $23.9M | Buy |
115,400
+102,600
| +802% | +$20.2M | 0.16% | 108 |
|
|
2018
Q2 | $2.36M | Sell |
12,800
-33,500
| -72% | -$5.93M | 0.01% | 816 |
|
|
2018
Q1 | $7.89M | Buy |
46,300
+45,600
| +6,514% | +$8.37M | 0.04% | 311 |
|
|
2017
Q4 | $122K | Sell |
700
-33,500
| -98% | -$5.93M | ﹤0.01% | 2301 |
|
|
2017
Q3 | $6.38M | Buy |
34,200
+22,800
| +200% | +$4.04M | 0.04% | 428 |
|
|
2017
Q2 | $1.96M | Sell |
11,400
-117,000
| -91% | -$19M | 0.01% | 940 |
|
|
2017
Q1 | $21.1M | Buy |
128,400
+92,700
| +260% | +$15.4M | 0.16% | 105 |
|
|
2016
Q4 | $5.22M | Buy |
35,700
+1,700
| +5% | +$256K | 0.03% | 556 |
|
|
2016
Q3 | $5.67M | Buy |
34,000
+33,900
| +33,900% | +$5.73M | 0.03% | 490 |
|
|
2016
Q2 | $15K | Sell |
100
-45,300
| -100% | -$7.04M | ﹤0.01% | 2044 |
|
|
2016
Q1 | $6.81M | Buy |
45,400
+14,800
| +48% | +$2.2M | 0.04% | 380 |
|
|
2015
Q4 | $4.97M | Buy |
30,600
+7,800
| +34% | +$1.23M | 0.03% | 475 |
|
|
2015
Q3 | $3.15M | Buy |
22,800
+10,500
| +85% | +$1.66M | 0.02% | 692 |
|
|
2015
Q2 | $1.89M | Sell |
12,300
-29,100
| -70% | -$4.66M | 0.01% | 941 |
|
|
2015
Q1 | $6.62M | Buy |
41,400
+2,600
| +7% | +$409K | 0.04% | 333 |
|
|
2014
Q4 | $6.18M | Sell |
38,800
-50,700
| -57% | -$7.9M | 0.04% | 363 |
|
|
2014
Q3 | $12.6M | Buy |
+89,500
| New | +$11.7M | 0.09% | 201 |
|
|
2013
Q4 | – | Sell |
-93,400
| Closed | -$10.5M | – | 1896 |
|
|
2013
Q3 | $10.5M | Buy |
+93,400
| New | +$10.1M | 0.1% | 169 |
|
Other funds holding AMGN
Jefferies Group's AMGN Position: Q3 2022 in Review
Jefferies Group increased its Amgen (AMGN) stake by 3,672% in Q3 2022, buying an estimated $17.8M and bringing the position to 75,480 shares worth $17M. The position accounts for 0.14% of the portfolio, ranked #112.
Jefferies Group first reported a position in AMGN in Q2 2013 and has held it in 37 quarters since. The position peaked at $48.6M in Q2 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Jefferies Group held 75,480 shares of Amgen worth $17M as of Q3 2022.
- Jefferies Group bought 73,479 Amgen shares in Q3 2022, an estimated $17.8M.
- Amgen made up 0.14% of Jefferies Group's portfolio in Q3 2022, its #112 holding.
- Jefferies Group first reported a position in Amgen in Q2 2013 and has held it in 37 quarters since.
- Jefferies Group's Amgen position peaked at $48.6M in Q2 2021.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.